#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary mediastinal large B-cell lymphoma Haemophilia B without inhibitors Fusarium infection Marginal zone lymphoma recurrent Atopic keratoconjunctivitis Phaeochromocytoma Liver abscess Congenital growth hormone deficiency Thyroid cancer metastatic Homocystinuria Hypereosinophilic syndrome Multiple system atrophy Candida infection Neuroendocrine cell hyperplasia of infancy Kearns-Sayre syndrome More trials…

    Learn about Rare Diseases

    Hereditary optic atrophy VEXAS syndrome – Basic Information Lysosomal storage disorder – Trials in Disease Lennox-Gastaut syndrome – Treatment Mastocytosis – Trials in Disease Myelodysplastic syndrome with excess blasts – Trials in Disease Mantle cell lymphoma – Diagnostics Haemophilia A without inhibitors – Basic Information Mitochondrial myopathy – Treatment Pulmonary sarcoidosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Irinotecan Hydrochloride Flortaucipir (18F) Cinnarizine Potassium Canrenoate F770/05 Encorafenib Rly-4008 Dextrose Bp Dobutamine Hydrochloride Concizumab Wt1 Mrna Dc Insulin Icodec Indacaterol Acetate Entinostat Quc398 Transpocart19 Ecoo18A Germanium (68Ge) Chloride Etavopivat Astegolimab More therapies…

    Learn about Your Condition

    Myocardial ischaemia Sinusitis bacterial Immune thrombocytopenia Follicular lymphoma stage IV Ovarian cancer Castleman's disease Ureteric cancer Brain injury Ulcerative keratitis Retinitis pigmentosa Childhood asthma Alveolar proteinosis Craniopharyngioma Endometrial cancer stage I Ligament operation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mkounl Zhsnfrmh Kzqma 2sd Dzzztggzx 4temg Hrjbwae

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Pembrolizumab and Enfortumab Vedotin with Surgery vs. Surgery Alone for Patients with Muscle-Invasive Bladder Cancer Who Cannot or Choose Not to Use Cisplatin

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Pembrolizumab
    Belgium Denmark France Germany Hungary Ireland +4

  • Study on Nipocalimab for Adults with Active Inflammatory Muscle Diseases

    Not recruiting

    2 1
    Investigated Drugs:
    • Nipocalimab
    Czechia France Germany Hungary Italy Poland +1

  • Study on the Safety and Tolerability of Epcoritamab with Drug Combination for Patients with B-cell Non-Hodgkin Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma refractory
    • B-cell lymphoma refractory
    Investigated Drugs:
    • Golcadomide
    • Polatuzumab Vedotin
    • Epcoritamab
    Czechia Denmark France Germany Hungary The Netherlands +1

  • Study Comparing Brentuximab Vedotin with Drug Combination for Treating Advanced Classical Hodgkin Lymphoma in Patients

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Bleomycin Sulfate
    • Bleomycin
    • Brentuximab Vedotin
    Belgium Czechia Denmark France Hungary Italy +3

  • Study of Venetoclax and Azacitidine for Maintenance Therapy in Patients with Acute Myeloid Leukemia in First Remission After Chemotherapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia (in remission)
    Investigated Drugs:
    • Azacitidine
    • Venetoclax
    Czechia France Germany Greece Hungary Italy +1

  • Study of TransCon TLR7/8 Agonist, TransCon IL-2 β/γ, and Pembrolizumab for Patients with Advanced Head and Neck Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Acp-017
    • Transcon Il-2Β/Γ
    • Pembrolizumab
    Germany Hungary Italy Poland Spain

  • Study on the Safety and Effectiveness of Ocrelizumab vs. Fingolimod for Children and Adolescents with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Relapsing-remitting multiple sclerosis
    Investigated Drugs:
    • DIMENHYDRINATE
    • Fingolimod
    • Methylprednisolone Sodium Succinate
    Austria Belgium Bulgaria Croatia Denmark Estonia +11

  • Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone Isonicotinate
    • Anakinra
    • Epcoritamab
    Austria Belgium Denmark Finland France Germany +7

  • Study on Nipocalimab for Adults with Warm Autoimmune Hemolytic Anemia

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Nipocalimab
    • Sodium Chloride
    Czechia France Germany Greece Hungary Italy +3

  • Study on the Effectiveness and Safety of Remibrutinib Compared to Placebo and Omalizumab in Adults with Chronic Spontaneous Urticaria Uncontrolled by Antihistamines

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Omalizumab
    • Remibrutinib
    Bulgaria Czechia France Germany Hungary Italy +4
Previous Page
1 … 32 33 34 35 36 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!